Access Statistics for Rena Conti

Author contact details at EconPapers.

Working Paper	File Downloads				Abstract Views
Working Paper	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Common Agent or Double Agent? Pharmacy Benefit Managers in the Prescription Drug Market	0	1	1	13	1	3	4	31
Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression	0	0	0	61	0	0	1	444
Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets	0	0	0	15	0	0	0	27
Pricing in the Market for Anticancer Drugs	0	0	0	59	0	0	5	108
Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007	0	0	0	80	0	1	3	73
The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts	0	0	0	16	0	0	0	78
The Generic Drug User Fee Amendments: An Economic Perspective	0	0	0	40	0	1	3	44
The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications	0	0	1	7	0	2	4	24
The Landscape of US Generic Prescription Drug Markets, 2004-2016	0	0	0	87	0	0	4	112
The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration	0	0	0	37	1	1	1	65
Valuing Rare Pediatric Drugs: An Economics Perspective	0	0	0	14	0	0	0	43
Total Working Papers	0	1	2	429	2	8	25	1,049

Journal Article	File Downloads				Abstract Views
Journal Article	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Pricing in the Market for Anticancer Drugs	0	0	0	21	0	1	3	134
Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices	0	0	0	0	0	3	5	5
Total Journal Articles	0	0	0	21	0	4	8	139

Chapter	File Downloads				Abstract Views
Chapter	Last month	3 months	12 months	Total	Last month	3 months	12 months	Total
Early Retirement and DI/SSI Applications: Exploring the Impact of Depression	0	0	0	15	0	0	0	49
How do Initial Signals of Quality Influence the Diffusion of New Medical Products? The Case of New Cancer Drug Treatments	0	0	0	2	0	1	2	5
Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007	0	0	2	27	0	0	6	101
Total Chapters	0	0	2	44	0	1	8	155

Authors with papers registered in the RePEc Author Service.

Authors with no registered papers

LogEc provides access and usage statistics for services based on the RePEc data set.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Statistics updated 2025-04-04